Trials
Search / Trial NCT06416046

Efficacy of Photobiomodulation in the Treatment and Relief of Pain in Recurrent Aphthous Stomatitis

Launched by FEDERAL UNIVERSITY OF RIO GRANDE DO SUL · May 15, 2024

Trial Information

Current as of February 19, 2025

Not yet recruiting

Keywords

ClinConnect Summary

Recurrent aphthous stomatitis (RAS) is the most common chronic ulcerative inflammatory disorder of the oral cavity, affecting approximately 20% of the general population, with no gender predilection. Its etiopathogenesis remains undefined, although factors such as local trauma and syndromes like Behcet's syndrome are implicated in predisposition. RAS manifests in three distinct clinical presentations, with the smallest being the most common, accounting for 80% of cases. Minor RAS present as round or oval ulcers, smaller than 1 cm, covered by a grayish-white pseudomembrane, commonly occurrin...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients over the age of 18
  • Patients presenting at least one painful mouth ulcer (minor ulcer), located on the tongue, jugal mucosa or labial mucosa, starting on the same day or the day before.
  • Exclusion Criteria:
  • Patients who have already undergone other treatment for RAS;
  • Patients with asymptomatic ulcers;
  • Patient must not be undergoing or have undergone any treatment for RAS;
  • Patients with any systemic condition related to RAS - e.g. Behcet's Syndrome, Periodic Fever Syndrome, Pharyngitis and Cervical Adenitis, HIV infection.

Trial Officials

Manoela Martins, PhD

Study Director

Federal University of Rio Grande do Sul

About Federal University Of Rio Grande Do Sul

The Federal University of Rio Grande do Sul (UFRGS) is a leading academic institution in Brazil, renowned for its commitment to research and innovation in various fields, including health sciences. As a prominent clinical trial sponsor, UFRGS leverages its extensive network of researchers and state-of-the-art facilities to advance medical knowledge and improve patient outcomes. The university is dedicated to conducting rigorous and ethically sound clinical studies, fostering collaborations with healthcare professionals, industry partners, and regulatory bodies to ensure the highest standards of scientific integrity and public health impact.

Locations

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0